The chief executive of GlaxoSmithKline tells the BBC that deal is good for employees The Lucozade and Ribena drinks brands have been sold by GlaxoSmithKline (GSK) to Japanese firm Suntory for £1.35bn.
Japanese drinks giant Suntory has confirmed it will buy the top-selling Lucozade and Ribena brands from British drugs firm GlaxoSmithKline (LSE: GSK.L - news) (GSK) for £1.34bn. The deal, part of ...
GlaxoSmithKline (LSE:GSK) today announced it has reached agreement to sell its nutritional drinks brands Lucozade and Ribena to Suntory Beverage & Food Ltd (SBF), the Japanese consumer goods company, ...
Japanese soft drinks giant Suntory is set to snap up iconic drinks brands Lucozade and Ribena after it was announced today it had agreed a £1.35bn cash deal with GlaxoSmithKline. Suntory Beverage & ...
Lucozade Ribena Suntory is to create a formal panel of legal advisers for the first time. It is the first legal review carried out by general counsel Mary Guest, who joined the company last November ...
LONDON/TOKYO, Sept 9 (Reuters) - Japan's Suntory Beverage & Food Ltd is to buy GlaxoSmithKline Plc's Lucozade and Ribena brands for 1.35 billion pounds ($2.11 billion) to help it expand into new ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
The Lucozade and Ribena drinks brands have been sold by GlaxoSmithKline (GSK) to Japanese firm Suntory for £1.35bn. Suntory already owns beverage firm Orangina Schweppes, and the deal is expected to ...
LONDON/TOKYO (Reuters) - Japan's Suntory Beverage & Food Ltd is to buy GlaxoSmithKline Plc's Lucozade and Ribena brands for 1.35 billion pounds ($2.1 billion) to help it expand into new markets. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results